VeriMomfucus vesiculosus extract hamilelikte güvenli mi?
No harmonised CLP classification or SCCS/CIR safety assessment indicating reproductive toxicity for Fucus vesiculosus extract; therefore default hazard = 0. Theoretical mechanism concern relates to seaweed-derived iodine (potential endocrine/thyroid effect) reported in the literature, but no demonstrated reproductive mechanism from topical cosmetic use (m=1). Topical cosmetic exposure is expected to be low but potentially measurable (e=1) rather than negligible. Sources: CosIng listing for Fucus vesiculosus extract, PubChem entry, PubMed literature on bladderwrack iodine content and systemic effects; no ECHA Annex VI harmonised classification nor SCCS/CIR repro flags.
Pregnancy-safe products containing fucus vesiculosus extract
Related ingredients
Frequently asked questions
- fucus vesiculosus extract hamilelikte güvenli mi?
- No harmonised CLP classification or SCCS/CIR safety assessment indicating reproductive toxicity for Fucus vesiculosus extract; therefore default hazard = 0. Theoretical mechanism concern relates to seaweed-derived iodine (potential endocrine/thyroid effect) reported in the literature, but no demonstrated reproductive mechanism from topical cosmetic use (m=1). Topical cosmetic exposure is expected to be low but potentially measurable (e=1) rather than negligible. Sources: CosIng listing for Fucus vesiculosus extract, PubChem entry, PubMed literature on bladderwrack iodine content and systemic effects; no ECHA Annex VI harmonised classification nor SCCS/CIR repro flags.
- fucus vesiculosus extract emzirirken güvenli mi?
- No data or regulatory classification indicating reproductive or lactation hazards from topical Fucus vesiculosus extract (h=0). Theoretical endocrine concern (iodine content) could affect maternal thyroid function and thereby lactation indirectly, but this is speculative without topical absorption data (m=1). Exposure from topical cosmetic use is expected to be low but measurable (e=1). Sources: CosIng, PubChem, PubMed; no harmonised CLP entries in ECHA Annex VI or SCCS/CIR warnings.
- fucus vesiculosus extract bebek cildi için güvenli mi?
- No evidence of developmental or infant-specific reproductive toxicity from Fucus vesiculosus extract (h=0). Theoretical mechanism remains iodine-related endocrine effects (m=1) but infant-specific mechanistic data are lacking. Because infant skin has higher absorption/surface-area-to-weight, assigned exposure is increased to moderate (e=2) when used topically on infants if the ingredient is present and absorption is plausible. Sources: CosIng, PubChem, general PubMed literature on iodine in seaweeds and infant thyroid sensitivity; no harmonised ECHA classification or SCCS/CIR contraindication for infant topical use found.
- VeriMom fucus vesiculosus extract nasıl puanlıyor?
- VeriMom fucus vesiculosus extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 87/100 (düşük risk) olarak puanlar.
- Hamilelikte fucus vesiculosus extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.